Loading...
The Financial Express

Pfizer in talks with India over expedited approval for coronavirus vaccine

| Updated: May 04, 2021 11:27:43


A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken on January 11, 2021 — Reuters/Files A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken on January 11, 2021 — Reuters/Files

Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its Covid-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."

Share if you like